Canada markets closed

Nanophase Technologies Corporation (NANX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1600+0.0900 (+8.41%)
At close: 03:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.0700
Open1.0600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0600 - 1.1900
52 Week Range0.3200 - 1.4900
Volume48,593
Avg. Volume11,601
Market Cap63.57M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Nanophase Reports Record First Quarter Results

    — Delivered $9.9 Million in Q1 Revenue— $0.9 Million in Profit— BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2024. Jess Jankowski

  • GlobeNewswire

    Nanophase Technologies Announces First Quarter 2024 Financial Release and Conference Call Details

    Romeoville, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2024 after market close on Tuesday, April 23, 2024, with an investor conference call to f

  • GlobeNewswire

    Nanophase Announces Successful Litigation Settlement

    ROMEOVILLE, Ill., April 11, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — announced today that it has agreed to a successful and amicable resolution of all ongoing litigation with BASF. The parties have executed a Settlement Agreement, an amendment to the